Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation). It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.
The Richtopian Vision
Join Our Newsletter
- 3,133,700 all-time readers
- 11 Amazing Examples of Disruptive Technology
- Green for Go: The Rise in Veganism and Changes in Consumer Consciousness
- What Is Social Marketing? And How Does It Work?
- 17 Great Examples of Effective Leadership and Strategy
- Workplace Culture: How to Encourage Collaboration
- 3 Reasons You Should Buy Gold (And 3 Reasons You Shouldn't)
- Business Etiquette Across Cultures (INFOGRAPHIC)
- The New Queen of Jewellery: An Interview With Alyssa Smith
- Grant Cardone Shares His Principles for Life & Success (Exclusive Interview)
- What Do the Super-Rich Spend Their Money On? (Infographic Included)
Women in Leadership
- 10 Popular Tools for Building Websites Online September 9, 2019